Denomme G. Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge. Rev Bras Hematol Hemater 2011;33;250–8.DenommeG.Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge. 2011;33;250–8.10.5581/1516-8484.20110067341576723049309Search in Google Scholar
Karafin MS, Blagg L, Tobian AAR, King KE, Ness PM, Savage Wj. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012;52:2087–93.KarafinMSBlaggLTobianAARKingKENessPMSavageWj.ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. 2012;52:2087–93.10.1111/j.1537-2995.2012.03574.x336013722339320Search in Google Scholar
Blumberg N, Refaai M, Heal J. ABO matching of platelet transfusions: “Start Making Sense.” Blood Transfus 2015;13:347–50.BlumbergNRefaaiMHealJ.ABO matching of platelet transfusions: “Start Making Sense.”2015;13:347–50.Search in Google Scholar
Harm SK, Yazer MH, Bub CB, et al. Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelets, and whole blood units tested by different methods. Transfusion 2019;59:762–67.HarmSKYazerMHBubCB, Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelets, and whole blood units tested by different methods. 2019;59:762–67.10.1111/trf.1508330548267Search in Google Scholar
Standards for blood banks and transfusion services. 31st ed. Arlington, VA: AABB, 2018:37–8.. 31st ed.Arlington, VA: AABB, 2018:37–8.Search in Google Scholar
Cid J, Harm SK, Yazer MH. Platelet transfusion: the art and science of compromise. Transfus Med Hemother 2013;40; 160–71.CidJHarmSKYazerMH.Platelet transfusion: the art and science of compromise. 2013;40; 160–71.10.1159/000351230372502023922541Search in Google Scholar
Dunbar NM, Katus MC, Freeman CM, Szczepiorkowski ZM. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions. Transfusion 2015;55:1882–8.DunbarNMKatusMCFreemanCMSzczepiorkowskiZM.Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions. 2015;55:1882–8.10.1111/trf.1307725757728Search in Google Scholar
Fontaine MJ, Webster J, Gomez S, Pham TD, Goodnough LT, Galel SA. How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets? Transfusion 2015;55:2783–9.FontaineMJWebsterJGomezSPhamTDGoodnoughLTGalelSA.How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?2015;55:2783–9.10.1111/trf.1337426448376Search in Google Scholar
Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma a survey of 3156 North American Laboratories. Arch Pathol Lab Med 2007;131: 909–16.FungMKDownesKAShulmanIA.Transfusion of platelets containing ABO-incompatible plasma a survey of 3156 North American Laboratories. 2007;131: 909–16.10.5858/2007-131-909-TOPCAP17550318Search in Google Scholar
Dunbar NM, Ornstein DL, Dumont LJ. ABO incompatible platelets: risk versus benefit. Curr Opin Hematol 2012;19: 475–9.DunbarNMOrnsteinDLDumontLJ.ABO incompatible platelets: risk versus benefit. 2012;19: 475–9.10.1097/MOH.0b013e328358b13522914587Search in Google Scholar
Chaudhary R, Sekhar Das S, Khetan D, Ojha S, Verma S. Comparative study of automated platelet apheresis using five different apheresis systems in a tertiary care hospital. Transfus Apher Sci 2009;40:99–103.ChaudharyRSekhar DasSKhetanDOjhaSVermaS.Comparative study of automated platelet apheresis using five different apheresis systems in a tertiary care hospital. 2009;40:99–103.10.1016/j.transci.2009.01.01619237317Search in Google Scholar
Berséus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion 2013;53:114S–123S.BerséusOBomanKNessenSCWesterbergLA.Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. 2013;53:114S–123S.10.1111/trf.1204523301963Search in Google Scholar
Strandenes G, Berseus O, Cap AP, et al. Low titer group O whole blood in emergency situations. Shock 2014;41:70–75.StrandenesGBerseusOCapAP, Low titer group O whole blood in emergency situations. 2014;41:70–75.10.1097/SHK.000000000000015024569505Search in Google Scholar
Flegel WA. Pathogenesis and mechanism of antibody-mediated hemolysis. Transfusion 2015;55:S47–S58.FlegelWA.Pathogenesis and mechanism of antibody-mediated hemolysis. 2015;55:S47–S58.10.1111/trf.13147450393126174897Search in Google Scholar
Hinz A, Enkel S, Zimmermann B, Lang P, Bakchoul T. Post transfusion hemolysis in a stem cell transplanted pediatric patient after receiving an apheresis platelet unit with high-titer Anti-A (abstract). Transfusionsmedizin 2018;8:160–3.HinzAEnkelSZimmermannBLangPBakchoulT.Post transfusion hemolysis in a stem cell transplanted pediatric patient after receiving an apheresis platelet unit with high-titer Anti-A (abstract). 2018;8:160–3.Search in Google Scholar
Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40:902–6.LarssonLGWelshVJLaddDJ.Acute intravascular hemolysis secondary to out-of-group platelet transfusion. 2000;40:902–6.10.1046/j.1537-2995.2000.40080902.x10960514Search in Google Scholar
Sadani DT, Urbaniak SJ, Bruce M, Tighe JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 2006;16:375–9.SadaniDTUrbaniakSJBruceMTigheJE.Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. 2006;16:375–9.10.1111/j.1365-3148.2006.00684.x16999762Search in Google Scholar
Shachner TR, Clark CT. Acute hemolytic transfusion reaction in group B recipient associated with group A apheresis platelet donor: case report and literature review. Case Rep Med 2018, article ID 8259531.ShachnerTRClarkCT.Acute hemolytic transfusion reaction in group B recipient associated with group A apheresis platelet donor: case report and literature review. 2018, article ID 8259531.10.1155/2018/8259531603581830034477Search in Google Scholar
Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. Clin Lab Haemat 1989;11:237–40.ReisMDCoovadiaAS.Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. 1989;11:237–40.10.1111/j.1365-2257.1989.tb00214.x2591154Search in Google Scholar
Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60–62.PierceRNReichLMMayerK.Hemolysis following platelet transfusions from ABO-incompatible donors. 1985;25:60–62.10.1046/j.1537-2995.1985.25185116506.x2578692Search in Google Scholar
Cunnion KM, Hair PS, Krishna NK, et al. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay. Transfusion 2016;56:1845–8.CunnionKMHairPSKrishnaNK, Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay. 2016;56:1845–8.10.1111/trf.1359226997226Search in Google Scholar
Valbonesi M, De Luigi MC, Lercari G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs 2000;23:642–6.ValbonesiMDe LuigiMCLercariG, Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. 2000;23:642–6.10.1177/039139880002300908Search in Google Scholar
Balbuena-Merle R, West BF, Tormey CA, Hendrickson JE. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution. Transfusion 2019;59:1911–5.Balbuena-MerleRWestBFTormeyCAHendricksonJE.Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution. 2019;59:1911–5.10.1111/trf.1524030865314Search in Google Scholar
Fontaine MJ, Mills AM, Weiss S, Hong WJ, Viele M, Goodnough LT. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products. Transfusion 2012;52:2081–5.FontaineMJMillsAMWeissSHongWJVieleMGoodnoughLT.How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products. 2012;52:2081–5.10.1111/j.1537-2995.2012.03596.x22414003Search in Google Scholar
Blumberg N, Heal JM, Hicks GL, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion 2001;41:790–3.BlumbergNHealJMHicksGLRisherWH.Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. 2001;41:790–3.10.1046/j.1537-2995.2001.41060790.x11399821Search in Google Scholar
FDA archived fatalities data due to transfusion/donation. Available from https://www.fda.gov/vaccines-blood-biologics/report-problem-center-biologics-evaluation-research/transfusiondonation-fatalities. Accessed 18 March 2019.. Available from https://www.fda.gov/vaccines-blood-biologics/report-problem-center-biologics-evaluation-research/transfusiondonation-fatalities. Accessed 18 March 2019.Search in Google Scholar
Karafin M, Fuller AK, Savage WJ, King KE, Ness PM, Tobian AAR. The impact of apheresis platelet manipulation on corrected count increment. Transfusion 2012;52:1221–7.KarafinMFullerAKSavageWJKingKENessPMTobianAAR.The impact of apheresis platelet manipulation on corrected count increment. 2012;52:1221–7.10.1111/j.1537-2995.2011.03476.x332535922233358Search in Google Scholar
Fung MK, Eder AF, Spitalnik SL, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: AABB, 2017.FungMKEderAFSpitalnikSLWesthoffCM.. 19th ed.Bethesda, MD: AABB, 2017.Search in Google Scholar
Josephson CD, Castillejo MI, Grima K, Hillyer CD. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci 2010;42:83–8.JosephsonCDCastillejoMIGrimaKHillyerCD.ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. 2010;42:83–8.10.1016/j.transci.2009.10.01320034854Search in Google Scholar
Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A,B: implications for transfusion policy. Transfusion 2004;44:805–8.JosephsonCDMullisNCVan DemarkCHillyerCD.Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A,B: implications for transfusion policy. 2004;44:805–8.10.1111/j.1537-2995.2004.03290.x15157243Search in Google Scholar
Weisberg SP, Shax BH, Tumer G, Silliman CC, Kelher MR, Cohn CS. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets. Transfusion 2018;58:891–5.WeisbergSPShaxBHTumerGSillimanCCKelherMRCohnCS.PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets. 2018;58:891–5.10.1111/trf.1452329473178Search in Google Scholar
Gulliksson H. Platelet storage media. Vox Sang 2014;107: 205–12.GullikssonH.Platelet storage media. 2014;107: 205–12.10.1111/vox.1217224976010Search in Google Scholar
Crosby WH, Akeroyd JH. Some immunohematologic results of large transfusions of group O blood in recipients of other blood groups. Blood 1954;9;103–16.CrosbyWHAkeroydJH.Some immunohematologic results of large transfusions of group O blood in recipients of other blood groups. 1954;9;103–16.10.1182/blood.V9.2.103.103Search in Google Scholar
Barns A. Transfusion of universal donor and uncrossmatched blood. Bibl Haematol 1980;46:132–42.BarnsA.Transfusion of universal donor and uncrossmatched blood. 1980;46:132–42.10.1159/0004305546990911Search in Google Scholar
Pietersz R, Engelfriet C, Reesink H. Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88:207–21.PieterszREngelfrietCReesinkH.Transfusion of apheresis platelets and ABO groups. 2005;88:207–21.10.1111/j.1423-0410.2005.00615.x15787735Search in Google Scholar
Cooling LL, Downs TA, Butch SH, Davenport RD. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion 2008;48:2106–13.CoolingLLDownsTAButchSHDavenportRD.Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. 2008;48:2106–13.10.1111/j.1537-2995.2008.01814.x18631162Search in Google Scholar
AuBuchon JP, Wildt-Eggen de J, Dumont LJ. Reducing the variation in performance of antibody titrations. Arch Pathol Lab Med 2008;132:1194–201.AuBuchonJPWildt-Eggen deJDumontLJ.Reducing the variation in performance of antibody titrations. 2008;132:1194–201.10.5858/2008-132-1194-RTVIPO18605771Search in Google Scholar
Bachegowda LS, Cheng YH, Long T, Shaz BH. Impact of uniform methods on interlaboratory antibody titration variability. Arch Pathol Lab Med 2017;141:131–8.BachegowdaLSChengYHLongTShazBH.Impact of uniform methods on interlaboratory antibody titration variability. 2017;141:131–8.10.5858/arpa.2015-0351-OA27681333Search in Google Scholar
Seheult JN, Anto V, Alarcon LH, Sperry JL, Triulzi DJ, Yazer MH. Clinical outcomes among low-titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation. Transfusion 2018;58: 1838–45.SeheultJNAntoVAlarconLHSperryJLTriulziDJYazerMH.Clinical outcomes among low-titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation. 2018;58: 1838–45.10.1111/trf.1477930160310Search in Google Scholar
Vanderspurt CK, Spinella PC, Cap AP et al. The use of whole blood in US military operations in Iraq, Syria, and Afghanistan since the introduction of low-titer type O whole blood: feasibility, acceptability, challenges. Transfusion 2019;59:965–70.VanderspurtCKSpinellaPCCapAPThe use of whole blood in US military operations in Iraq, Syria, and Afghanistan since the introduction of low-titer type O whole blood: feasibility, acceptability, challenges. 2019;59:965–70.Search in Google Scholar
Condron M, Scanlan M, Schreiber M. Massive transfusion of low-titer cold-stored O-positive whole blood in civilian trauma setting. Transfusion 2019;59:927–30.CondronMScanlanMSchreiberM.Massive transfusion of low-titer cold-stored O-positive whole blood in civilian trauma setting. 2019;59:927–30.10.1111/trf.1509130592054Search in Google Scholar
Park ES, Jo KI, Shin JW, et al. Comparison of total and IgG ABO antibody titers in healthy individuals by using tube and column agglutination techniques. Ann Lab Med 2014;34: 223–9.ParkESJoKIShinJW, Comparison of total and IgG ABO antibody titers in healthy individuals by using tube and column agglutination techniques. 2014;34: 223–9.10.3343/alm.2014.34.3.223399932124790910Search in Google Scholar
Kang SJ, Lim YA, Baik SY. Comparison of ABO antibody titers on the basis of the antibody detection method used. Ann Lab Med 2014;34:300.KangSJLimYABaikSY.Comparison of ABO antibody titers on the basis of the antibody detection method used. 2014;34:300.10.3343/alm.2014.34.4.300407118724982835Search in Google Scholar
Matsuura H, Akatsuka Y, Matsuno T, et al. Comparison of the tube test and column agglutination techniques for anti-A/-B antibody titration in healthy individuals. Vox Sang 2018;113:787–94.MatsuuraHAkatsukaYMatsunoT, Comparison of the tube test and column agglutination techniques for anti-A/-B antibody titration in healthy individuals. 2018;113:787–94.10.1111/vox.1271330251432Search in Google Scholar
Quillen K, Sheldon SL, Daniel-Johnson JL, Lee-Stroka H, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. Transfusion 2011;51:92–6.QuillenKSheldonSLDaniel-JohnsonJLLee-StrokaHFlegelWA.A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. 2011;51:92–6.10.1111/j.1537-2995.2010.02759.x368292520576015Search in Google Scholar
ARUP Laboratory Test Directory. Available from http://ltd.aruplab.com/tests/pub/2000280. Accessed 23 May 2017.. Available from http://ltd.aruplab.com/tests/pub/2000280. Accessed 23 May 2017.Search in Google Scholar
Boorman KE, Dodd BE, Mollison PL. Iso-immunisation to the blood-group factors A, B and Rh. J Pathol Bacteriol 1945;57:157–69.BoormanKEDoddBEMollisonPL.Iso-immunisation to the blood-group factors A, B and Rh. 1945;57:157–69.10.1002/path.1700570202Search in Google Scholar
Koskela P, Nurmi T, Haiva V-M. IgA, IgG and IgM anti-blood group A antibodies induced by pneumococcal vaccine. Vaccine 1988;6:221–2.KoskelaPNurmiTHaivaV-M.IgA, IgG and IgM anti-blood group A antibodies induced by pneumococcal vaccine. 1988;6:221–2.10.1016/0264-410X(88)90214-9Search in Google Scholar
Bourke GJ, Clarke N. Smallpox vaccination and serum anti-A levels. Acta Genet Stat Med 1965;15:13–20.BourkeGJClarkeN.Smallpox vaccination and serum anti-A levels. 1965;15:13–20.Search in Google Scholar
Gupte SC, Bhatia HM. Anti-A and anti-B titer response after tetanus toxoid injections in normal adults and pregnant women. Indian J Med Res 1979;70:221–8.GupteSCBhatiaHM.Anti-A and anti-B titer response after tetanus toxoid injections in normal adults and pregnant women. 1979;70:221–8.Search in Google Scholar
Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845–9.Daniel-JohnsonJLeitmanSKleinH, Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. 2009;49:1845–9.10.1111/j.1537-2995.2009.02208.x342102619453987Search in Google Scholar
McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products. Am J Clin Pathol 1999;111:202–6.McManigalSSimsKL.Intravascular hemolysis secondary to ABO incompatible platelet products. 1999;111:202–6.10.1093/ajcp/111.2.2029930141Search in Google Scholar
Galvão de França ND, Cristovão Poli MC, Almeida Ramos PG, Rocha Borsoi CS, Colella R. Titers of ABO antibodies in group O blood donors. Rev Bras Hematol Hemoter 2011;33:259–262.Galvão de FrançaNDCristovão PoliMCAlmeida RamosPGRocha BorsoiCSColellaR.Titers of ABO antibodies in group O blood donors. 2011;33:259–262.10.5581/1516-8484.20110073341575223049315Search in Google Scholar
Bazigou F, Lempesopoulos K, Kavallierou L, et al. Evaluation of anti-A and anti-B alloisogglutinin titer in group O plateletpheresis donors. Hematol Transfus Int J 2015;1:00017.BazigouFLempesopoulosKKavallierouL, Evaluation of anti-A and anti-B alloisogglutinin titer in group O plateletpheresis donors. 2015;1:00017.Search in Google Scholar
Byrne KM, Sheldon SL, Flegel WA. Organization and management of an accredited Specialist in Blood Bank (SBB) Technology program. Transfusion 2010;50:1612–7.ByrneKMSheldonSLFlegelWA.Organization and management of an accredited Specialist in Blood Bank (SBB) Technology program. 2010;50:1612–7.10.1111/j.1537-2995.2010.02737.x339091221175473Search in Google Scholar